ULAB SYSTEMS, INC.

Profile

Company Names

ULAB SYSTEMS, INC.

Addresses

7005 APPLING FARMS PARKWAY, STE. 103, MEMPHIS, TN 38133

1820 GATEWAY DRIVE, SUITE 300, SAN MATEO, CA 94404

Phone Numbers

650-804-1397

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$90,961,221.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-02-18 
$20,000.00 
$20,000.00 
$0.00 
Debt 
1
2021-04-01 
$90,941,221.00 
$109,567,800.00 
$18,626,579.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
AMIR 
 
ABOLFATHI 
EXECUTIVE OFFICER, DIRECTOR
NEXTBIO   |  SONITUS MEDICAL INC   |  RODO MEDICAL, INC.   |  SONITUS TECHNOLOGIES INC.   |  ADVANCED ENT SOLUTIONS INC   |  TUSKER MEDICAL, INC.   |  ULAB SYSTEMS, INC.   |  R3 VASCULAR INC.   |  BRIUS TECHNOLOGIES, INC.   |  VENTARIS SURGICAL, INC.
HAL 
 
BECKHAM 
EXECUTIVE OFFICER
ULAB SYSTEMS, INC.
ROBIN 
 
BIENFAIT 
DIRECTOR
ULAB SYSTEMS, INC.   |  SENTEON INC.
ROBERT 
 
DOTY 
EXECUTIVE OFFICER
ULAB SYSTEMS, INC.
NICOLA 
 
DOWNES 
EXECUTIVE OFFICER
PNEUMRX INC   |  ULAB SYSTEMS, INC.
TIM 
 
DUMORE 
DIRECTOR
ULAB SYSTEMS, INC.
TIM 
 
DUNMORE 
DIRECTOR
ULAB SYSTEMS, INC.
MIC 
 
FALKEL 
EXECUTIVE OFFICER
PIPSTEK, LLC   |  ULAB SYSTEMS, INC.
MARK 
 
FOLEY 
DIRECTOR
SONITUS MEDICAL INC   |  SONITUS TECHNOLOGIES INC.   |  AMALFI SEMICONDUCTOR INC   |  AMBIQ MICRO, INC.   |  HINT INC \ DE   |  ULAB SYSTEMS, INC.
DANIEL 
 
GORBACK 
EXECUTIVE OFFICER
ULAB SYSTEMS, INC.
ROBIN 
 
MCCORD 
EXECUTIVE OFFICER
ULAB SYSTEMS, INC.
RITA 
 
O-CONNOR 
DIRECTOR
PLX PHARMA INC.   |  ULAB SYSTEMS, INC.
AMIRALI 
 
TALASAZ 
DIRECTOR
GUARDANT HEALTH, INC.   |  ULAB SYSTEMS, INC.
DAVID 
 
THROWER 
EXECUTIVE OFFICER
INSOUND MEDICAL INC   |  BIOLUX RESEARCH HOLDINGS, INC.   |  AERIN MEDICAL INC.   |  TRIAGENICS, INC   |  ULAB SYSTEMS, INC.
HUAFENG 
 
WEN 
DIRECTOR, EXECUTIVE OFFICER
ULAB SYSTEMS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-10-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-01 
2022-09-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-01 
2022-03-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-02-18 
2021-06-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-01 
2021-04-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#